Beta-adrenergic drugs and risk of Parkinson’s disease: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Beta-adrenergic drugs and risk of Parkinson’s disease: A systematic review and meta-analysis

Published:2022-09 Issue: Volume:80 Page:101670
ISSN:1568-1637
Container-title:Ageing Research Reviews
language:en
Short-container-title:Ageing Research Reviews

Author:

Singh Ambrish,Hussain Salman,Akkala Sreelatha,Klugarová Jitka,Pokorná Andrea,Klugar Miloslav,Walters E. Haydn,Hopper Ingrid,Campbell Julie A.,Taylor Bruce,Antony Benny

Publisher

Elsevier BV

Subject

Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology

Reference48 articles.

1. Use of antihypertensives and the risk of Parkinson disease;Becker;Neurology,2008

2. Hall IP. β(2) Agonists;Billington;Handb. Exp. Pharm.,2017

3. Effects of β2-Adrenergic Agonists on Risk of Parkinson’s Disease in COPD: A Population-Based Study;Chen;Pharmacotherapy,2020

4. Risk of developing Parkinson’s disease among patients with asthma: a nationwide longitudinal study;Cheng;Allergy,2015

5. Cochrane C. Review manager (version 5.4.1)[computer software]. The Cochrane Collaboration: Copenhagen, Denmark. 2014.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease;Neurology;2023-11-21

2. Biases in Electronic Health Records Data for Generating Real-World Evidence: An Overview;Journal of Healthcare Informatics Research;2023-11-14

3. Chronic diseases and multimorbidity patterns, their recent onset, and risk of new-onset Parkinson's disease and related functional degeneration in older adults: a prospective cohort study;eClinicalMedicine;2023-11

4. Type 2 diabetes mellitus as a determinant factor for the age of ParkinsonÓ?s disease onset;Revista Mexicana de Neurociencia;2023-02-15

5. Recent Advances in the Study of Na+/K+-ATPase in Neurodegenerative Diseases;Cells;2022-12-16